MicroRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells

DNA and Cell Biology

Volumn 35, Issue 12, 2016, Pages 828-835

  Kong, Xiangjie ^a   Qian, Xiaoqiang ^a   Duan, Liujian ^a   Liu, Hailong ^a   Zhu, Yingjian ^a   Qi, Jun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

invasion; migration; MiR 372; p65; PCA

Indexed keywords

CYCLIN DEPENDENT KINASE 8; GELATINASE B; MICRORNA; MICRORNA 372; PROSTATE SPECIFIC ANTIGEN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; TUMOR MARKER; UNCLASSIFIED DRUG; LUCIFERASE; MIRN372 MICRORNA, HUMAN;

ADULT; ARTICLE; CELL ACTIVITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALE; MIDDLE AGED; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROTEIN TARGETING; TUMOR SUPPRESSOR GENE; AGED; BLOOD; CANCER STAGING; CELL CYCLE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROSTATE; PROSTATE TUMOR; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

AGED; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 85003696218     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2015.3186     Document Type: Article

References (41)

1. Aalinkeel, R., Nair, M.P., Sufrin, G., Mahajan, S.D., Chadha, K.C., Chawda, R.P., and Schwartz, S.A. (2004). Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Cancer Res 64, 5311-5321.
2. Annunziata, C.M., Davis, R.E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., Dave, S., Hurt, E.M., Tan, B., Zhao, H., Stephens, O., Santra, M., Williams, D.R., Dang, L., Barlogie, B., Shaughnessy, J.D., Jr., Kuehl, W.M., and Staudt, L.M. (2007). Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12, 115-130.
3. Chen, C.D., and Sawyers, C.L. (2002). NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol Cell Biol 22, 2862-2870.
4. Chen, L.F., and Greene, W.C. (2004). Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5, 392-401.
5. Cho, W.J., Shin, J.M., Kim, J.S., Lee, M.R., Hong, K.S., Lee, J.H., et al. (2009). miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol Cells 28, 521-527.
6. Corey, E., Brown, L.G., Kiefer, J.A., Quinn, J.E., Pitts, T.E., Blair, J.M., and Vessella, R.L. (2005). Osteoprotegerin in prostate cancer bone metastasis. Cancer Res 65, 1710-1718.
7. Cortez, M.A., Bueso-Ramos, C., Ferdin, J., Lopez-Berestein, G., Sood, A.K., and Calin, G.A. (2011). MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 8, 467-477.
8. Dalmay, T., and Edwards, D.R. (2006). MicroRNAs and the hallmarks of cancer. Oncogene 25, 6170-6175.
9. Diamandis, E.P. (2010). Prostate cancer screening with prostate-specific antigen testing: more answers or more confusion? Clin Chem 56, 345-351.
10. DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin, M. (1997). A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388, 548-554.
11. Dykxhoorn, D.M. (2010). MicroRNAs and metastasis: little RNAs go a long way. Cancer Res 70, 6401-6406.
12. Egan, A., Dong, Y., Zhang, H., Qi, Y., Balk, S.P., and Sartor, O. (2014). Castration-resistant prostate cancer: adaptive responses in the androgen axis. Cancer Treat Rev 40, 426-433.
13. Ezhevsky, S.A., Nagahara, H., Vocero-Akbani, A.M., Gius, D.R., Wei, M.C., and Dowdy, S.F. (1997). Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci USA 94, 10699-10704.
14. Fradet, V., Lessard, L., Begin, L.R., Karakiewicz, P., Masson, A.M., and Saad, F. (2004). Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clin Cancer Res 10, 8460-8464.
15. Ghosh, S., and Karin, M. (2002). Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl, S81-S96.
16. Griffiths-Jones, S., Grocock, R.J., van Dongen, S., Bateman, A., and Enright, A.J. (2006). miRBase: microRNA sequences, targets and genenomenclature.Nucleic AcidsRes 34, D140-D144.
17. Gu, H., Guo, X., Zou, L., Zhu, H., and Zhang, J. (2013). Up-regulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma. Mol Cell Biochem 375, 23-30.
18. Hu, J., Wang, Z., Liao, B.Y., Yu, L., Gao, X., Lu, S., Wang, S., Dai, Z., Zhang, X., Chen, Q., Qiu, S.J., Wu, Y., Zhu, H., Fan, J., Zhou, J., and Wang, J. (2014). Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients. Int J Cancer 135, 1187-1194.
19. Ismail, H.A., Lessard, L., Mes-Masson, A.M., and Saad, F. (2004). Expression of NF-kappaB in prostate cancer lymph node metastases. Prostate 58, 308-313.
20. Koumakpayi, I.H., Le Page, C., Mes-Masson, A.M., and Saad, F. (2010). Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signal-ling pathway and prognostic significance in prostate cancer. Br J Cancer 102, 1163-1173.
21. Lai, J.H., She, T.F., Juang, Y.M., Tsay, Y.G., Huang, A.H., Yu, S.L., et al. (2012). Comparative proteomicproling of human lung adenocarcinoma cells (CL1-0) expressing miR-372. Electrophoresis 33, 675-688.
22. Lessard, L., Karakiewicz, P.I., Bellon-Gagnon, P., Alam-Fahmy, M., Ismail, H.A., Mes-Masson, A.M., and Saad, F. (2006). Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases. Clin Cancer Res 12, 5741-5745.
23. Lessard, L., Mes-Masson, A.M., Lamarre, L., Wall, L., Lattouf, J.B., and Saad, F.(2003).NF-kappaBnuclearlocalization andits prognostic significance in prostate cancer. BJU Int 91, 417-420.
24. Lilja, H., Ulmert, D., and Vickers, A.J. (2008). Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer 8, 268-278.
25. Lin, K., Lipsitz, R., Miller, T., Janakiraman, S., U.S. Preventive Services Task Force. (2008). Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 149, 192-199.
26. Liu, D., Tao, T., Xu, B., Chen, S., Liu, C., Zhang, L., Lu, K., Huang, Y., Jiang, L., Zhang, X., Huang, X., Zhang, L., Han, C., and Chen, M. (2014). MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6). Biochem Biophys Res Commun 445, 151-156.
27. Liu, D.X., and Greene, L.A. (2001). Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res 305, 217-228.
28. Mestdagh, P., Lefever, S., Pattyn, F., Ridzon, D., Fredlund, E., Fieuw, A., Ongenaert, M., Vermeulen, J., De Paepe, A., Wong, L., Speleman, F., Chen, C., and Vandesompele, J. (2011). The microRNA body map: dissecting microRNA function through integrative genomics. Nucleic Acids Res 39, e136.
29. Mundy, G.R. (2002). Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2, 584-593.
30. Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M.A., and Daidone, M.G. (2005). Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65, 5506-5511.
31. Schroder, F.H. (2009). Review of diagnostic markers for prostate cancer. Recent Results Cancer Res 181, 173-182.
32. Siegel, R., Naishadham, D., and Jemal, A. (2013). Cancer statistics, 2013. CA Cancer J Clin 63, 11-30.
33. Sturge, J., Caley, M.P., and Waxman, J. (2011). Bone metastasis in prostate cancer: emerging therapeutic strategies. Nat Rev Clin Oncol 8, 357-368.
34. Uzzo, R.G., Crispen, P.L., Golovine, K., Makhov, P., Hor-witz, E.M., and Kolenko, V.M. (2006). Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: impli-cations for prostate cancer progression. Carcinogenesis 27, 1980-1990.
35. Webber, M.M., Waghray, A., and Bello, D. (1995). Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res 1, 1089-1094.
36. Weber, J.A., Baxter, D.H., Zhang, S., Huang, D.Y., Huang, K.H., Lee, M.J., Galas, D.J., and Wang, K. (2010). The microRNA spectrum in 12 body fluids. Clin Chem 56, 1733-1741.
37. Wu, G., Wang, Y., Lu, X., He, H., Liu, H., Meng, X., Xia, S., Zheng, K., and Liu, B. (2015). Low mir-372 expression correlates with poor prognosis and tumor metastasis in he-patocellular carcinoma. BMC Cancer 15, 182.
38. Wu, Z., Sun, H., Zeng, W., He, J., and Mao, X. (2012). Upre-gulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS One 7, e45825.
39. Xu, B., Wang, N., Wang, X., Tong, N., Shao, N., Tao, J., Li, P., Niu, X., Feng, N., Zhang, L., Hua, L., Wang, Z., and Chen, M. (2012). MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer. Prostate 72, 1171-1178.
40. Zhang, L., Charron, M., Wright, W.W., Chatterjee, B., Song, C.S., Roy, A.K., and Brown, T.R. (2004). Nuclear factor-kappaB activates transcription of the androgen receptor gene in Sertoli cells isolated from testes of adult rats. Endocrinology 145, 781-789.
41. Zhu, C., Li, J., Ding, Q., Cheng, G., Zhou, H., Tao, L., Cai, H., Li, P., Cao, Q., Ju, X., Meng, X., Qin, C., Hua, L., Shao, P., and Yin, C. (2013). miR-152 controls migration and invasive potential by targeting TGFalpha in prostate cancer cell lines. Prostate 73, 1082-1089.